The 2020 WHO Classification of Tumors of Bone: An Updated Review.
Choi JH, Ro JY.
Adv Anat Pathol. 2021 May 1;28(3):119-138. doi: 10.1097/PAP.0000000000000293.
Outcomes and Management of Positive Margins in Chondrosarcoma With Soft Tissue Extension: A Case Series and Review of Literature.
Yu A, Poulson T, Butler Z, Demetrious M, Gitelis S, Blank AT.
Cancer Rep (Hoboken). 2025 Mar;8(3):e70148. doi: 10.1002/cnr2.70148.
Dedifferentiated chondrosarcoma.
Mercuri M, Picci P, Campanacci L, Rulli E.
Skeletal Radiol. 1995 Aug;24(6):409-16. doi: 10.1007/BF00941235.
Chondrosarcomas revisited.
Mavrogenis AF, Gambarotti M, Angelini A, Palmerini E, Staals EL, Ruggieri P, Papagelopoulos PJ.
Orthopedics. 2012 Mar 7;35(3):e379-90. doi: 10.3928/01477447-20120222-30.
Cartilaginous tumours of soft tissue.
Fletcher CD, Krausz T.
Appl Pathol. 1988;6(3):208-20.
Calcified Chondroid Mesenchymal Neoplasm: Exploring the Morphologic and Clinical Features of an Emergent Entity With a Series of 33 Cases.
Kallen ME, Michal M, Meyer A, Suster DI, Olson NJ, Charville GW, Perret R, Gross JM.
Am J Surg Pathol. 2023 Jun 1;47(6):725-737. doi: 10.1097/PAS.0000000000002044. Epub 2023 Apr 27.
The unsuspected soft tissue chondrosarcoma.
Mackenzie DH.
Histopathology. 1983 Sep;7(5):759-66. doi: 10.1111/j.1365-2559.1983.tb02288.x.
Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases.
Nakashima Y, Unni KK, Shives TC, Swee RG, Dahlin DC.
Cancer. 1986 Jun 15;57(12):2444-53. doi: 10.1002/1097-0142(19860615)57:12<2444::aid-cncr2820571233>3.0.co;2-k.
Management of pelvic sarcoma.
Lee JS, Kelly CM, Bartlett EK.
Eur J Surg Oncol. 2022 Nov;48(11):2299-2307. doi: 10.1016/j.ejso.2022.09.011. Epub 2022 Sep 17.
Dedifferentiated chondrosarcoma: current standards of care.
Kattepur AK, Jones RL, Gulia A.
Future Oncol. 2021 Dec;17(35):4983-4991. doi: 10.2217/fon-2021-0830. Epub 2021 Nov 4.
